Flexion Therapeutics

Flexion Therapeutics (NASDAQ: FLXN) is a biopharmaceutical company focused on the development & commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions. Flexion is based in Burlington, Massachusetts. View our terms of use: https://flexiontherapeutics.com/terms-of-use/ Mission:?As a lean biopharmaceutical team, our goal is to cost effectively develop and commercialize novel therapies that will provide safe, substantial and sustained pain relief to the sufferers of musculoskeletal (MSK) diseases, the first of which is OA. We focus on product candidates that provide long-lasting analgesia locally while avoiding systemic side effects.